Abstract
The blood-brain barrier is the structure that maintains central nervous system homeostasis; it is composed of brain endothelial cells, astroglia, pericytes, microglia, and of the extracellular matrix components basal lamina and glycocalyx. The blood-brain barrier constitutes the main interface between the brain and the periphery; therefore it is the main structure regulating the passage of molecules from blood-to-brain and vice versa. At brain endothelial cells are expressed numerous members of the solute carrier (SLC) and ATP-binding cassette (ABC) gene families; those carriers exert selective transport and preclude free exchange of molecules from blood-to-brain. In addition, brain endothelial cells present low paracellular diffusion and vesicle-mediated transport. The regulation of the blood-brain barrier permeability is essential to guarantee nutrient supply to brain cells, but also to allow selective passage of drugs designed to treat brain diseases. This review describes both the pharmacological and physiological approaches to modulate the permeability of the blood-brain barrier. Finally we propose that once more data on blood-brain barrier normal physiology are obtained, health professionals will be able to take advantage of normal variations in blood-brain barrier permeability to administer drugs aimed to affect the central nervous system in the critical time window of blood-brain barrier “opening”.
Keywords: blood-brain barrier permeability, brain endothelial cells, caveolae, receptor-mediated endocytosis, carrier systems, tight junctions, Beta-catenin, homotypically, paracellular leukocyte, lipophilic, neovascularization, abluminal, Plasminogen, diencephalon, dementia.
Current Psychopharmacology
Title:From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier
Volume: 1
Author(s): B. Gomez-Gonzalez, K. Sanchez-Alegria and J. Velazquez-Moctezuma
Affiliation:
Keywords: blood-brain barrier permeability, brain endothelial cells, caveolae, receptor-mediated endocytosis, carrier systems, tight junctions, Beta-catenin, homotypically, paracellular leukocyte, lipophilic, neovascularization, abluminal, Plasminogen, diencephalon, dementia.
Abstract: The blood-brain barrier is the structure that maintains central nervous system homeostasis; it is composed of brain endothelial cells, astroglia, pericytes, microglia, and of the extracellular matrix components basal lamina and glycocalyx. The blood-brain barrier constitutes the main interface between the brain and the periphery; therefore it is the main structure regulating the passage of molecules from blood-to-brain and vice versa. At brain endothelial cells are expressed numerous members of the solute carrier (SLC) and ATP-binding cassette (ABC) gene families; those carriers exert selective transport and preclude free exchange of molecules from blood-to-brain. In addition, brain endothelial cells present low paracellular diffusion and vesicle-mediated transport. The regulation of the blood-brain barrier permeability is essential to guarantee nutrient supply to brain cells, but also to allow selective passage of drugs designed to treat brain diseases. This review describes both the pharmacological and physiological approaches to modulate the permeability of the blood-brain barrier. Finally we propose that once more data on blood-brain barrier normal physiology are obtained, health professionals will be able to take advantage of normal variations in blood-brain barrier permeability to administer drugs aimed to affect the central nervous system in the critical time window of blood-brain barrier “opening”.
Export Options
About this article
Cite this article as:
Gomez-Gonzalez B., Sanchez-Alegria K. and Velazquez-Moctezuma J., From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier, Current Psychopharmacology 2012; 1 (3) . https://dx.doi.org/10.2174/2211556011201030214
DOI https://dx.doi.org/10.2174/2211556011201030214 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?
Letters in Drug Design & Discovery Analytical Procedure for Determination of Cyclooxygenase-2 Inhibitors in Biological Fluids by High Performance Liquid Chromatography: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects
Current Alzheimer Research Past, Present and Future of Nutrigenomics and its Influence on Drug Development
Current Drug Discovery Technologies Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery TAU Aggregation is a Therapeutic Target for Alzheimers Disease
Current Alzheimer Research Current Therapy and Computational Drug Designing Approaches for Neurodegenerative Diseases -with Focus on Alzheimer’s and Parkinson’s.
Current Signal Transduction Therapy Complement and Microglia in the Neuropathogenesis of HIV Infection: Pro- and Anti-Inflammatory Aspects
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Population-Based Study of Cholesterol Measurements in the Oldest Old
Current Aging Science Pathways of Acetylcholine Synthesis, Transport and Release as Targets for Treatment of Adult-Onset Cognitive Dysfunction
Current Medicinal Chemistry From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer’s Disease
Current Medicinal Chemistry Molecular Linkages Between Diabetes and Alzheimer's Disease: Current Scenario and Future Prospects
CNS & Neurological Disorders - Drug Targets Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases
Current Medicinal Chemistry Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation
Current Alzheimer Research Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo
Current Pharmaceutical Design P2Y Receptors in the Mammalian Nervous System: Pharmacology, Ligands and Therapeutic Potential
CNS & Neurological Disorders - Drug Targets NO to Breast: When, Why and Why Not?
Current Pharmaceutical Design Translational Methods for Non-Invasive Electrical Stimulation to Facilitate Gait Rehabilitation Following Stroke - The Future Directions
Neuroscience and Biomedical Engineering (Discontinued) Neuromodulation of Memory Formation and Extinction
Current Neurovascular Research The Role of ER Stress-Induced Apoptosis in Neurodegeneration
Current Alzheimer Research